Named on one round in the feed.
Since 2023-10-01
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Kasvu Therapeutics A company developing a new generation of neuroplastogens for neuropsychiatric and neurodegenerative disorders | Series A Verified against 15 sources[ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts. | $34.2M | 2023-10-01 | [ PART ] |